Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Therapeutic Advances in Hematology|June 6, 2022
The importance of terminal complement inhibition in paroxysmal nocturnal hemoglobinuriaAustin G Kulasekararaj, Robert A Brodsky, Jun-Ichi Nishimura, et al.
Hematology (Amsterdam, Netherlands)|February 2, 2023
A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell diseaseLianne E Rotin, Auro Viswabandya, Rajat Kumar, et al.
Journal of Clinical Apheresis|August 1, 2016
How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice surveyChristopher J Patriquin, William F Clark, Katerina Pavenski, et al.
Thrombosis and Haemostasis|December 22, 2011
Study of Octaplex dosing accuracy: an in vitro analysisChristopher J Patriquin, Ian H Chin-Yee, Michael J Kovacs, et al.
European Journal of Haematology|March 25, 2023
Fatigue and health-related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analysis of the pegcetacoplan PEGASUS trial dataJens Panse, Koo Wilson, Jesse Fishman, et al.
Journal of Clinical Apheresis|July 3, 2020
The practical integration of a hybrid model of ultrasound-guided peripheral venous access in a large apheresis centerDavid Barth, Rosaleen M Nemec, Dennis D Cho, et al.
British Journal of Haematology|March 25, 2016
Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpuraChristopher J Patriquin, Mari R Thomas, Tina Dutt, et al.
Leukemia & Lymphoma|June 3, 2020
Efficacy and safety of stem cell mobilization following gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy in patients with relapsed or refractory lymphomaCatherine Tang, Osvaldo Espin-Garcia, Anca Prica, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 7, 2023
Therapeutic plasma exchange in alloimmune platelet refractorinessSheharyar Raza, Christopher J Patriquin, Karen Yee, et al.
American Journal of Hematology|March 7, 2026
Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH RegistryAlexander Röth, Christopher J Patriquin, Jeff Szer, et al.
Pageof 4